ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP42425 Hepatitis A, B, Typhoid and Rabies Vaccines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 30 Sept 2026, 00:59.

Opportunity overview

Supply of Hepatitis A, B, Typhoid and Rabies Vaccines to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

GlaxoSmithKline

Match pending…
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
14 Jul 2025
Suppliers
One of 2 awarded suppliers
Award ID
050711-2025-1
Status
active
Location
Brentford, UK, TW8 9GS, United Kingdom

Merck Sharp & Dohme UK Ltd

Match pending…
Shared contract value
£3.4m
Awarded
Not supplied
Contract signed
14 Jul 2025
Suppliers
One of 2 awarded suppliers
Award ID
050711-2025-1
Status
active
Location
HODDESDON, UK, EC2M 6UR., United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Contract Notice for Goods – Framework without Lots - Supply of Hepatitis A, B, Typhoid and Rabies vaccines to NHS Scotland. The Authority intends to award this framework as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.£5.4m

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-050c57
Status
complete
Has Recurrence
No
Review Details
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
3 Jun 2025, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
9,999,999

Expected award period

Starts
3 Jun 2025, 12:00

Tender Period

Ends
3 Jun 2025, 12:00

Contract terms

Has Electronic Payment
Yes
Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Bid Validity Period

Duration In Days
90

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Contract Notice for Goods - Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

Applies To

supplier
Criterion 2
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. OR (a) Confirmation of existence of a valid and current UK Manufacturing 'Specials' License approved by the MHRA. Confirmation of such a license should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. OR All of the Goods classed as unlicensed medicines will be manufactured at a site holding a valid and current UK Manufacturing ‘Specials' licence approved by MHRA. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

Applies To

supplier

Lots and requirements

Entry 1
Id
1
Status
cancelled
Has Options
No
Has Renewal
No
Description
Contract Notice for Goods – Framework without Lots - Supply of Hepatitis A, B, Typhoid and Rabies vaccines to NHS Scotland. The Authority intends to award this framework as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Value

Amount
5,400,000
Currency
GBP

Award criteria

Criteria

Criterion 1
Name
Logistics
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
1,440

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Name
Michael Welsh
Telephone
+44 1312756000
Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House
Organisation 3
Id
GB-FTS-11330
Name
GlaxoSmithKline

Roles

supplier

Address

Region
UK
Locality
Brentford
Postal Code
TW8 9GS
Country Name
United Kingdom
Street Address
980 Great West Road

Details

Scale
large

Identifier

Legal Name
GlaxoSmithKline

Contact

Telephone
+44 7876130839
Organisation 4
Id
GB-FTS-25701
Name
Merck Sharp & Dohme UK Ltd

Roles

supplier

Address

Region
UK
Locality
HODDESDON
Postal Code
EC2M 6UR.
Country Name
United Kingdom
Street Address
120 Moorgate, London, United Kingdom

Details

Scale
large

Identifier

Legal Name
Merck Sharp & Dohme UK Ltd

Contact

Telephone
+44 1992455245

Award information

Award 1
Id
050711-2025-1
Status
active

Suppliers

Supplier 1
Id
GB-FTS-11330
Name
GlaxoSmithKline
Supplier 2
Id
GB-FTS-25701
Name
Merck Sharp & Dohme UK Ltd

Related lots

1

Contracts and changes

Entry 1
Id
050711-2025-1
Status
active
Award ID
050711-2025-1
Date Signed
15 Jul 2025, 00:00

Value

Amount
3,404,952
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-050c57-2025-08-22T09:27:00+01:00compiled ·